We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Gilead Science (GILD) Followers
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
960 89 0 GILD
Emcee:  SybilNicolas Type:  Unmoderated
Any one offer insight about the potential of GILD? It just has an AIDS drug approved by FDA.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
960Inhaled version tipped “It is not a cure,” O’Day says. “It is a Wildbiftek-5/15/2020
959Gilead has yet to set a price for the coronavirus treatment remdesivir, but an iGlenn Petersen-5/5/2020
958Having belatedly watched the video, the statement was clearly prepared, so I preA.J. Mullen-4/29/2020
957That is encouraging for patients and very encouraging for stockholders, but IA.J. Mullen-4/29/2020
956I think Fauci said the >1000 pt study, 15 days (placebo) vs 11 days (treatmenSnowShredder-4/29/2020
955More on the trial: "The results suggested a survival benefit, wiWildbiftek-4/29/2020
954I think this statement is pretty clear cut: Dr. Anthony Fauci said at the WhiteWildbiftek14/29/2020
953..quite good news doesn't sound like gushing enthusiasm. Fauci called the sA.J. Mullen-4/29/2020
952Not what I'm hearing: Anthony Fauci, the head of NIAID and the government’sWildbiftek-4/29/2020
951From initial Fauci report, data are nothing close to strong, actually weak. MortMiljenko Zuanic-4/29/2020
950This afternoon!Miljenko Zuanic14/29/2020
949Do you now when we get the results from the placebo trial? AshleyA.J. Mullen-4/29/2020
948Issue is 800 pts NIAID placebo trial, how strong are data??? twitter.comMiljenko Zuanic-4/29/2020
947They said 64.5% of the patients who received the shorter treatment course were dA.J. Mullen-4/29/2020
946Gilead says early results of coronavirus drug trial show improvement with shorteGlenn Petersen-4/29/2020
945STAT Plus video chat: What we know about Gilead’s remdesivir data Note: The acGlenn Petersen34/19/2020
944GILD product makes the cover of WAPO again U.S. stocks soar after drug trial shzax-4/17/2020
943Gilead Sciences, Inc. (GILD) 76.54 +1.91 (+2.56%) 87.00 +10.46 (13.67%) Atzax-4/16/2020
942Early peek at data on Gilead coronavirus drug suggests patients are responding tGlenn Petersen14/16/2020
941GILD runs out of severe pts. to enroll in China I had been skeptical oWildbiftek-4/13/2020
940I suspect GILD will see a nice bump on Monday... courtesy the cover of today'zax-4/11/2020
939GILD is not expensive. Forward PE is 11.5 And dividend yield is 3.7% It is a valBrian Sullivan14/11/2020
938GILD 73.51 -2.0% Two-Thirds of Severe Covid-19 Cases Improved on Gilead Drug zax-4/10/2020
937NEJM article is out with inconclusive but very hopeful results for remdesivir: Wildbiftek-4/10/2020
936Coronavirus Fighter Gilead Sciences Might Be Expensive, but It’s Still Worth Ownzax-4/6/2020
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):